Biofrontera (BFRI) Total Current Liabilities (2020 - 2025)
Biofrontera has reported Total Current Liabilities over the past 6 years, most recently at $11.9 million for Q4 2025.
- For Q4 2025, Total Current Liabilities fell 1.05% year-over-year to $11.9 million; the TTM value through Dec 2025 reached $11.9 million, down 1.05%, while the annual FY2025 figure was $11.9 million, 1.05% down from the prior year.
- Total Current Liabilities for Q4 2025 was $11.9 million at Biofrontera, down from $12.6 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $29.1 million in Q3 2023 and troughed at $9.3 million in Q2 2024.
- A 5-year average of $15.3 million and a median of $13.8 million in 2021 define the central range for Total Current Liabilities.
- Biggest five-year swings in Total Current Liabilities: soared 213.03% in 2021 and later tumbled 62.12% in 2024.
- Year by year, Total Current Liabilities stood at $13.8 million in 2021, then surged by 51.01% to $20.9 million in 2022, then fell by 13.43% to $18.1 million in 2023, then plummeted by 33.54% to $12.0 million in 2024, then decreased by 1.05% to $11.9 million in 2025.
- Business Quant data shows Total Current Liabilities for BFRI at $11.9 million in Q4 2025, $12.6 million in Q3 2025, and $19.7 million in Q2 2025.